Literature DB >> 7490159

Radial artery compliance in young, obese, normotensive subjects.

A A Mangoni1, C Giannattasio, A Brunani, M Failla, M Colombo, G Bolla, F Cavagnini, G Grassi, G Mancia.   

Abstract

Obesity is characterized by a number of cardiovascular alterations, and whether these alterations involve arterial compliance is unknown. In 12 young, obese, normotensive subjects (age, 23.9 +/- 1.3 years; mean +/- SEM) and 12 age- and sex-matched lean control subjects we measured blood pressure, radial artery diameter, and radial artery compliance continuously over the systodiastolic pressure range with a Finapres device and recently developed echo-tracking device. Measurements were obtained at baseline and after prolonged ischemia, that is, when diameter and compliance are increased. Blood pressure values were normal in both groups (obese subjects: 109.2 +/- 4.9/68.2 +/- 2.7 mm Hg; lean control subjects: 108.2 +/- 4.1/60.7 +/- 3.8 mm Hg), but in addition to a marked increase in body mass index (38.5 +/- 0.8 versus 23.1 +/- 0.9 kg/m2, P < .01), obese subjects showed a slight and nonsignificant increase in heart rate (71.1 +/- 3.2 versus 66.7 +/- 3.3 beats per minute, P = NS), increases in left ventricular wall thickness and left ventricular mass index (121.5 +/- 4.8 versus 103.4 +/- 3.3 kg/m2, P < .01), no changes in plasma renin activity and plasma norepinephrine (compared with normal values), and a marked reduction in total body glucose uptake (glucose clamp technique). Obese subjects showed radial artery diameter and compliance values that were greater than those seen in control subjects throughout the systodiastolic pressure range. The differences were 13% (P < .05) and 96% (P < .01), respectively, and both diameter and compliance remained higher in obese than lean subjects after forearm ischemia. In obese and lean subjects baseline radial artery diameter values correlated highly with body weight, body surface area, and body mass index.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7490159     DOI: 10.1161/01.hyp.26.6.984

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  7 in total

1.  Is obesity predictive of cardiovascular dysfunction independent of cardiovascular risk factors?

Authors:  E DeVallance; S B Fournier; D A Donley; D E Bonner; K Lee; J C Frisbee; P D Chantler
Journal:  Int J Obes (Lond)       Date:  2014-06-24       Impact factor: 5.095

Review 2.  Vascular compliance in diabetes.

Authors:  Nathaniel Winer; James R Sowers
Journal:  Curr Diab Rep       Date:  2003-06       Impact factor: 4.810

3.  Brachial-to-radial systolic blood pressure amplification in patients with type 2 diabetes mellitus.

Authors:  R E D Climie; D S Picone; M A Keske; J E Sharman
Journal:  J Hum Hypertens       Date:  2015-10-08       Impact factor: 3.012

4.  Effects of acute and chronic interval sprint exercise performed on a manually propelled treadmill on upper limb vascular mechanics in healthy young men.

Authors:  T Dylan Olver; Steph M Reid; Alan R Smith; Mair Zamir; Peter W R Lemon; M Harold Laughlin; J Kevin Shoemaker
Journal:  Physiol Rep       Date:  2016-07

Review 5.  Arterial stiffness in insulin resistance: the role of nitric oxide and angiotensin II receptors.

Authors:  Divina G Brillante; Anthony J O'Sullivan; Laurence G Howes
Journal:  Vasc Health Risk Manag       Date:  2009-04-08

6.  Iron Stores, Hepcidin, and Aortic Stiffness in Individuals with Hypertension.

Authors:  Luca Valenti; Alessandro Maloberti; Stefano Signorini; Marta Milano; Francesca Cesana; Fabrizio Cappellini; Paola Dongiovanni; Marianna Porzio; Francesco Soriano; Maura Brambilla; Giancarlo Cesana; Paolo Brambilla; Cristina Giannattasio; Silvia Fargion
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

Review 7.  Hypertension in the metabolic syndrome and diabetes: pathogenesis, clinical studies, and treatment.

Authors:  Joseph L Izzo
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Nov-Dec       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.